{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:18:45Z","timestamp":1754151525712,"version":"3.41.2"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11845-025-03958-9","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T07:26:09Z","timestamp":1745479569000},"page":"1017-1019","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment to: \u201cTreatment of a STAT5b::RAR\u03b1 positive case of APL in a patient not eligible for intensive chemotherapy\u201d"],"prefix":"10.1007","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0974-9512","authenticated-orcid":false,"given":"Zhan","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianlan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianqi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"3958_CR1","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1007\/s11845-024-03751-0","volume":"1971\u2013193","author":"J Patterson","year":"2024","unstructured":"Patterson J, Clarke K, Mokretar K et al (2024) Treatment of a STAT5b::RAR\u03b1 positive case of APL in a patient not eligible for intensive chemotherapy. Ir J Med Sci 1971\u2013193:2875\u20132881. https:\/\/doi.org\/10.1007\/s11845-024-03751-0","journal-title":"Ir J Med Sci"},{"key":"3958_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00428-022-03447-9","volume":"482","author":"M Rudelius","year":"2023","unstructured":"Rudelius M, Weinberg OK, Niemeyer CM et al (2023) The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia. Virchows Arch 482:113\u2013130. https:\/\/doi.org\/10.1007\/s00428-022-03447-9","journal-title":"Virchows Arch"},{"key":"3958_CR3","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3760\/cma.j.issn.1009-9921.2016.11.006","volume":"25","author":"F Huang","year":"2016","unstructured":"Huang F, Qu X, Xu J et al (2016) Acute promyelocytic leukemia associated with rare variant fusion gene STAT5b-RAR\u03b1: report of two cases and review of literature. J Leuk Lymphoma 25:663\u2013667. https:\/\/doi.org\/10.3760\/cma.j.issn.1009-9921.2016.11.006","journal-title":"J Leuk Lymphoma"},{"key":"3958_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3760\/cma.j.issn.1009-9921.2019.04.010","volume":"28","author":"W Cai","year":"2019","unstructured":"Cai W, Xiao X, Li C (2019) Acute promyelocytic leukemia with STAT5b-RAR\u03b1 fusion gene positive: report of one case and review of literature. J Leuk Lymphoma 28:235\u2013237. https:\/\/doi.org\/10.3760\/cma.j.issn.1009-9921.2019.04.010","journal-title":"J Leuk Lymphoma"},{"key":"3958_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3760\/cma.j.issn.0253-2727.2020.03.014","volume":"41","author":"R Mi","year":"2020","unstructured":"Mi R, Chen lin, Liu J, et al (2020) Clinical analysis of 10 patients of acute promyelocytic leukemia with a variant RAR\u03b1 translocation. Chin J Hematol 41:257\u2013260. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2020.03.014","journal-title":"Chin J Hematol"},{"key":"3958_CR6","unstructured":"zhang H (2021) A preliminary study on drug resistance mechanism of acute promyelocytic leukemia with positive STAT5B-RAR\u03b1 fusion gene. Doctoral dissertation, Nanchang University"},{"key":"3958_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3760\/cma.j.cn115356-20230828-00028","volume":"33","author":"Q Guo","year":"2024","unstructured":"Guo Q, Fan H, Gao S et al (2024) Acute promyelocytic leukemia with STAT5b::RAR\u03b1 fusion gene: report of 1 case and review of literature. J Leuk Lymphoma 33:224\u2013227. https:\/\/doi.org\/10.3760\/cma.j.cn115356-20230828-00028","journal-title":"J Leuk Lymphoma"},{"key":"3958_CR8","doi-asserted-by":"publisher","unstructured":"Su Z, Liu X, (2021) Comment on Geoffroy, M.-C., de Th\u00e9, H. Classic and variants APLs, as viewed from a therapy response. Cancers, (2020) 12, 967. Cancers 13:5883. https:\/\/doi.org\/10.3390\/cancers13235883","DOI":"10.3390\/cancers13235883"},{"key":"3958_CR9","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1182\/blood.2024023883","volume":"144","author":"X Zhou","year":"2024","unstructured":"Zhou X, Chen X, Chen J et al (2024) Critical role of tripartite fusion and LBD truncation in certain RARA - and all RARG -related atypical APL. Blood 144:1471\u20131485. https:\/\/doi.org\/10.1182\/blood.2024023883","journal-title":"Blood"},{"key":"3958_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022923","volume":"99","author":"L Wang","year":"2020","unstructured":"Wang L, Yan X, He J (2020) Does acute promyelocytic leukemia patient with the STAT5B\/RARa fusion gene respond well to decitabine?: a case report and literature review. Medicine (Baltimore) 99. https:\/\/doi.org\/10.1097\/MD.0000000000022923","journal-title":"Medicine (Baltimore)"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-03958-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-025-03958-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-03958-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T04:19:14Z","timestamp":1752898754000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-025-03958-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3958"],"URL":"https:\/\/doi.org\/10.1007\/s11845-025-03958-9","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"type":"print","value":"0021-1265"},{"type":"electronic","value":"1863-4362"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"For this type of study, informed consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"For this type of study, informed consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}